SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-073597
Filing Date
2023-09-05
Accepted
2023-09-05 08:37:50
Documents
100
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea184404-6k_procaps.htm   iXBRL 6-K 19235
2 UNAUDITED INTERIM FINANCIAL STATEMENTS FOR THE THREE AND SIX MONTHS ENDED JUNE 3 ea184404ex99-1_procaps.htm   iXBRL EX-99.1 1101233
3 SUPPLEMENTARY FINANCIAL INFORMATION RELATING TO THE THREE AND SIX MONTHS ENDED J ea184404ex99-2_procaps.htm EX-99.2 181190
4 GRAPHIC ex99-2_001.jpg GRAPHIC 3564
5 GRAPHIC ex99-2_002.jpg GRAPHIC 2284
  Complete submission text file 0001213900-23-073597.txt   7422739

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE proc-20230630.xsd EX-101.SCH 120434
7 XBRL CALCULATION FILE proc-20230630_cal.xml EX-101.CAL 50263
8 XBRL DEFINITION FILE proc-20230630_def.xml EX-101.DEF 312057
9 XBRL LABEL FILE proc-20230630_lab.xml EX-101.LAB 637223
10 XBRL PRESENTATION FILE proc-20230630_pre.xml EX-101.PRE 334882
94 EXTRACTED XBRL INSTANCE DOCUMENT ea184404-6k_procaps_htm.xml XML 1451548
Mailing Address 9 RUE DE BITBOURG LUXEMBOURG N4 L-1273
Business Address 9 RUE DE BITBOURG LUXEMBOURG N4 L-1273 575-371-9280
Procaps Group, S.A. (Filer) CIK: 0001863362 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40851 | Film No.: 231234231
SIC: 2834 Pharmaceutical Preparations